A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment
Purpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2017-01-01
|
Series: | Journal of Medical Physics |
Subjects: | |
Online Access: | http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=Ogretici |
id |
doaj-77368880338d41e793977f76d2dab0e1 |
---|---|
record_format |
Article |
spelling |
doaj-77368880338d41e793977f76d2dab0e12020-11-25T00:05:37ZengWolters Kluwer Medknow PublicationsJournal of Medical Physics0971-62031998-39132017-01-0142312813210.4103/jmp.JMP_133_16A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatmentAkın OgreticiAydın ÇakırUğur AkbaşCanan KöksalÜmmühan KalafatMakbule TambaşHatice BilgePurpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity modulated radiation therapy technique. Materials and Methods: TPS factor was evaluated with two different planning algorithms: Anisotropic analytical algorithm and Acuros XB (external beam). To evaluate the shielding factor, a standard radiological purpose lead apron was chosen. For both studies, thermoluminescence dosimeters were used to measure the point dose, and an Alderson RANDO-phantom was used to simulate a female pregnant patient in this study. Thirteen measurement points were chosen in the 32nd slice of the phantom to cover all possible locations of a fetus up to 8th week of gestation. Results: The results show that both of the TPS algorithms are incapable of calculating the fetal doses, therefore, unable to reduce them at the planning stage. Shielding with a standard lead apron, however, showed a slight radiation protection (about 4.7%) to the fetus decreasing the mean fetal dose from 84.8 mGy to 80.8 mGy, which cannot be disregarded in case of fetal irradiation. Conclusions: Using a lead apron for shielding the abdominal region of a pregnant patient during breast irradiation showed a minor advantage; however, its possible side effects (i.e., increased scattered radiation and skin dose) should also be investigated further to solidify its benefits.http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=OgreticiFetal doseintensity modulated radiation therapypregnancyshieldingtreatment planning system |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Akın Ogretici Aydın Çakır Uğur Akbaş Canan Köksal Ümmühan Kalafat Makbule Tambaş Hatice Bilge |
spellingShingle |
Akın Ogretici Aydın Çakır Uğur Akbaş Canan Köksal Ümmühan Kalafat Makbule Tambaş Hatice Bilge A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment Journal of Medical Physics Fetal dose intensity modulated radiation therapy pregnancy shielding treatment planning system |
author_facet |
Akın Ogretici Aydın Çakır Uğur Akbaş Canan Köksal Ümmühan Kalafat Makbule Tambaş Hatice Bilge |
author_sort |
Akın Ogretici |
title |
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
title_short |
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
title_full |
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
title_fullStr |
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
title_full_unstemmed |
A phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
title_sort |
phantom study on fetal dose reducing factors in pregnant patients with breast cancer during radiotherapy treatment |
publisher |
Wolters Kluwer Medknow Publications |
series |
Journal of Medical Physics |
issn |
0971-6203 1998-3913 |
publishDate |
2017-01-01 |
description |
Purpose: This study aims to investigate the factors that reduce fetal dose in pregnant patients with breast cancer throughout their radiation treatment. Two main factors in a standard radiation oncology center are considered as the treatment planning systems (TPSs) and simple shielding for intensity modulated radiation therapy technique. Materials and Methods: TPS factor was evaluated with two different planning algorithms: Anisotropic analytical algorithm and Acuros XB (external beam). To evaluate the shielding factor, a standard radiological purpose lead apron was chosen. For both studies, thermoluminescence dosimeters were used to measure the point dose, and an Alderson RANDO-phantom was used to simulate a female pregnant patient in this study. Thirteen measurement points were chosen in the 32nd slice of the phantom to cover all possible locations of a fetus up to 8th week of gestation. Results: The results show that both of the TPS algorithms are incapable of calculating the fetal doses, therefore, unable to reduce them at the planning stage. Shielding with a standard lead apron, however, showed a slight radiation protection (about 4.7%) to the fetus decreasing the mean fetal dose from 84.8 mGy to 80.8 mGy, which cannot be disregarded in case of fetal irradiation. Conclusions: Using a lead apron for shielding the abdominal region of a pregnant patient during breast irradiation showed a minor advantage; however, its possible side effects (i.e., increased scattered radiation and skin dose) should also be investigated further to solidify its benefits. |
topic |
Fetal dose intensity modulated radiation therapy pregnancy shielding treatment planning system |
url |
http://www.jmp.org.in/article.asp?issn=0971-6203;year=2017;volume=42;issue=3;spage=128;epage=132;aulast=Ogretici |
work_keys_str_mv |
AT akınogretici aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT aydıncakır aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT ugurakbas aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT canankoksal aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT ummuhankalafat aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT makbuletambas aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT haticebilge aphantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT akınogretici phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT aydıncakır phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT ugurakbas phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT canankoksal phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT ummuhankalafat phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT makbuletambas phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment AT haticebilge phantomstudyonfetaldosereducingfactorsinpregnantpatientswithbreastcancerduringradiotherapytreatment |
_version_ |
1725424201943220224 |